Introduction
Tendon tissue engineering research has achieved significant progress but remains facing the challenge of limited cell source. For example, harvesting autologous tenocytes may cause secondary donor tendon defect, bone marrow stem cells still can not be differentiated into tenocytes with high efficiency, dermal fibroblasts are limited to allogenic application. Adipose derived stem cells (ASCs) are an easily accessible cell source without causing major donor site defect. Rare investigation of using ASCs for in vitro tendon engineering and in vivo tendon defect repair has been reported. This study aimed to explore the possibility of using ASC for tendon engineering and reconstruction.
Materials and Methods
Autologous ASCs were acquired from New Zealand rabbit nuchal subcutaneous adipose with collagenase digestion, cultured and expanded to second passage, then seeded on longitudinally arranged polyglycolic acids (PGA) fibers rolled by PLGA network. Cell-scaffold constructs were cultivated in a special stretching bioreactor for 5 weeks to avoid parts of acids produced by PGA fibers (n=12 for each group) before in vivo implantation to repair defect of Achilles tendon. Scaffold only were used as the control. Specimens were respectively harvested at 12, 21, and 45 weeks post operation for gross, histological, and mechanical analyses.
Results
The cells were found attach well to PGA fibers post-seeding and produce abundant extracellular matrices. After 5 weeks of dynamic cultivation, cell-scaffold constructs with good biomechanical properties (tensile stress ~50MPa, about 50% of normal tendon) were generated in experimental group. At 12 weeks post operation, most of PLGA networks were still existed complete grossly but became much weaker (only 15% of normal tendon) probably contributed to scaffold degradation. Longer observation of engineered tendons showed more similar properties to normal tendon. At 21 weeks, parallel collagen alignment was observed at both ends, but not in the middle in histology, with more cellular components than natural tendons, with tensile stress reached to 55% of normal tendon again. At 45 weeks, engineered tendons exhibited similar histology to natural tendon. Collagens became parallel throughout the tendon structure, and PGA/PLGA fibers were completely degraded. Furthermore, engineered tendons shew stronger mechanical properties with tensile strength reached to 80MPa, relatively mature collagen with fibril diameter around 100nm at 45 weeks, collagen fibers were longitudinally aligned, more and more approaching to native rabbit tendon structure with increasing time. At 12 weeks in control group, neo-tissue was formed only at the peripheral area by host cells, and the formed tissue was histologically disorganized and mechanically weaker than cell-engineered tendons (p >0.05).
Discussion and Conclusions
Above results suggested that ASC could be considered as a practical cell source to replace tenocytes for in vitro tendon tissue engineering and possibly in vivo tendon repair. Further study of the long term existence of implanted cells would benefit to better understanding of the new formed tendon remodeling.
